Table 2 Baseline laboratory data of the study population.

From: Neutrophil to albumin ratio predicts cardiovascular and all cause mortality in CVD patients with abnormal glucose metabolism

Characteristics

Tertiles of NPAR

P value

total

T1

T2

T3

HbA1c, %

6.43(0.03)

6.26(0.04)

6.45(0.06)

6.58(0.06)

 < 0.0001

eGFR, mL/min/1.73m2

73.66(0.52)

77.18(0.73)

74.85(0.90)

68.84(0.98)

 < 0.0001

LDL-cholesterol, mmol/L

2.63(0.03)

2.72(0.04)

2.70(0.05)

2.47(0.04)

 < 0.0001

HDL-cholesterol, mmol/L

1.25(0.01)

1.26(0.02)

1.22(0.02)

1.26(0.02)

0.11

TC, mmol/L

4.74(0.03)

4.85(0.05)

4.84(0.06)

4.51(0.05)

 < 0.0001

TG, mmol/L

1.97(0.03)

2.03(0.06)

2.06(0.06)

1.81(0.05)

 < 0.001

Scr, umol/L

94.78(1.17)

88.76(1.01)

92.78(1.95)

102.97(2.39)

 < 0.0001

LDH, IU/L

144.53(0.95)

143.54(1.19)

143.97(1.72)

146.13(1.65)

0.41

Uric acid, umol/L

359.45(2.42)

355.89(3.26)

354.92(4.15)

367.72(4.63)

0.05

Albumin, g/L

4.12(0.01)

4.29(0.01)

4.17(0.01)

3.90(0.01)

 < 0.0001

BUN, mmol/L

6.31(0.06)

5.81(0.08)

6.17(0.10)

6.96(0.13)

 < 0.0001

AST, IU/L

25.54(0.41)

26.66(0.46)

25.68(0.66)

24.26(0.85)

0.03

ALT, IU/L

24.66(0.59)

25.69(0.52)

25.46(1.06)

22.78(1.37)

0.14

TBil, umol/L

11.30(0.12)

11.33(0.17)

11.44(0.24)

11.14(0.19)

0.5

GGT, IU/L

35.45(1.10)

36.49(1.96)

35.96(2.20)

33.88(1.45)

0.46

  1. Data are presented as mean (SD) or n (%).
  2. HbA1c, glycated hemoglobin; eGFR, Estimated Glomerular Filtration Rate; LDL-cholesterol, Low-Density Lipoprotein Cholesterol; HDL-cholesterol, High-Density Lipoprotein Cholesterol; TC, Total Cholesterol; TG, Triglycerides; Scr, Serum Creatinine; LDH, Lactate Dehydrogenase; Uric acid, Uric Acid; Albumin, Serum Albumin; BUN, Blood Urea Nitrogen; AST, Aspartate Aminotransferase; ALT, Alanine Aminotransferase; TBil, Total Bilirubin; GGT, Gamma-Glutamyl Transferase.
Back to article page